Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

Similar articles for PubMed (Select 24663086)


Albumin suppresses human hepatocellular carcinoma proliferation and the cell cycle.

Nojiri S, Joh T.

Int J Mol Sci. 2014 Mar 24;15(3):5163-74. doi: 10.3390/ijms15035163.


Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells.

Shimizu M, Suzui M, Deguchi A, Lim JT, Xiao D, Hayes JH, Papadopoulos KP, Weinstein IB.

Clin Cancer Res. 2004 Oct 1;10(19):6710-21.


Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells.

Wu Q, Qin SK, Teng FM, Chen CJ, Wang R.

J Hematol Oncol. 2010 Oct 31;3:43. doi: 10.1186/1756-8722-3-43.


Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines.

Liu H, Qin CY, Han GQ, Xu HW, Meng M, Yang Z.

World J Gastroenterol. 2007 Mar 21;13(11):1652-8.


FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801.

Yamaguchi F, Hirata Y, Akram H, Kamitori K, Dong Y, Sui L, Tokuda M.

BMC Cancer. 2013 Oct 10;13:468. doi: 10.1186/1471-2407-13-468.


The expression and effects the CABYR-c transcript of CABYR gene in hepatocellular carcinoma.

Li H, Fang L, Xiao X, Shen L.

Bull Cancer. 2012 Mar 1;99(3):E26-33. doi: 10.1684/bdc.2011.1538.


Homocysteine inhibits hepatocyte proliferation via endoplasmic reticulum stress.

Yu X, Lv J, Zhu Y, Duan L, Ma L.

PLoS One. 2013;8(1):e54265. doi: 10.1371/journal.pone.0054265. Epub 2013 Jan 22.


Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D.

Das SK, Hashimoto T, Kanazawa K.

Biochim Biophys Acta. 2008 Apr;1780(4):743-9. doi: 10.1016/j.bbagen.2008.01.003. Epub 2008 Jan 12.


A novel anticancer agent, SKLB70359, inhibits human hepatic carcinoma cells proliferation via G0/G1 cell cycle arrest and apoptosis induction.

Dai XY, Zeng XX, Peng F, Han YY, Lin HJ, Xu YZ, Zhou T, Xie G, Deng Y, Mao YQ, Yu LT, Yang L, Zhao YL.

Cell Physiol Biochem. 2012;29(1-2):281-90. doi: 10.1159/000337609. Epub 2012 Mar 1.


Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.

Cai X, Hu X, Cai B, Wang Q, Li Y, Tan X, Hu H, Chen X, Huang J, Cheng J, Jing X.

Oncol Rep. 2013 Nov;30(5):2449-57. doi: 10.3892/or.2013.2718. Epub 2013 Sep 4.


Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.

Li J, Chen X, Dong X, Xu Z, Jiang H, Sun X.

J Gastroenterol Hepatol. 2006 Dec;21(12):1814-20.


Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.

Wei S, Xiong M, Zhan DQ, Liang BY, Wang YY, Gutmann DH, Huang ZY, Chen XP.

Carcinogenesis. 2012 Mar;33(3):538-47. doi: 10.1093/carcin/bgr319. Epub 2012 Jan 5.


Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma.

Gao Y, Lin LP, Zhu CH, Chen Y, Hou YT, Ding J.

Cancer Biol Ther. 2006 Aug;5(8):978-85. Epub 2006 Aug 3.


UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.

Wu G, Lin N, Xu L, Liu B, Feitelson MA.

BMC Cancer. 2013 Mar 28;13:167. doi: 10.1186/1471-2407-13-167. Erratum in: BMC Cancer. 2014;14:216. Feitelson, Mark A [added].


miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.

Hernandez JM, Elahi A, Clark CW, Wang J, Humphries LA, Centeno B, Bloom G, Fuchs BC, Yeatman T, Shibata D.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S625-35. doi: 10.1245/s10434-013-3106-3. Epub 2013 Jul 18.


Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway.

Chen XZ, Cao ZY, Chen TS, Zhang YQ, Liu ZZ, Su YT, Liao LM, Du J.

Oncol Rep. 2012 Aug;28(2):742-8. doi: 10.3892/or.2012.1834. Epub 2012 May 25.


Antitumor activity of di-n-butyl-(2,6-difluorobenzohydroxamato)tin(IV) against human gastric carcinoma SGC-7901 cells via G2/M cell cycle arrest and cell apoptosis.

Yunlan L, Juan Z, Qingshan L.

PLoS One. 2014 Mar 18;9(3):e90793. doi: 10.1371/journal.pone.0090793. eCollection 2014.


ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.

Zheng L, Liang P, Li J, Huang XB, Liu SC, Zhao HZ, Han KQ, Wang Z.

PLoS One. 2012;7(9):e45412. doi: 10.1371/journal.pone.0045412. Epub 2012 Sep 25.


Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium.

Tang B, Du J, Wang J, Tan G, Gao Z, Wang Z, Wang L.

Oncol Rep. 2012 Apr;27(4):1090-6. doi: 10.3892/or.2011.1580. Epub 2011 Dec 6.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk